Guozhong Yi
Guangzhou Dadao Bei Street 1838
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population.
Journal: Research (Washington, D.C.)
Published: July 19, 2025
Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 04, 2025
A Novel C19orf47-AKT2 Chimeric RNA Generated by Cis-Splicing of Adjacent Genes Is Associated With Glioblastoma Prognosis.
Journal: Annals of clinical and translational neurology
Published: March 29, 2025
Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment.
Journal: Genes & diseases
Published: April 18, 2024
Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy.
Journal: Cancer biology & therapy
Published: August 21, 2023
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
Journal: Journal of neuro-oncology
Published: June 20, 2023
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Journal: Molecular biomedicine
Published: May 13, 2023
Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme.
Journal: Current medicinal chemistry
Published: May 12, 2023
A Four-Gene Panel for the Prediction of Prognosis and Immune Cell Enrichment in Gliomas.
Journal: Molecular biotechnology
Published: March 08, 2023
Applying the en-bloc technique in corpus callosum glioblastoma surgery contributes to maximal resection and better prognosis: a retrospective study.
Journal: BMC surgery
Published: January 14, 2023
IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 10, 2022
Last Updated: 09/26/2026